Moreover, serum IL-10 levels were decreased in patients with benign mixed carcinoma without metastasis (MC-BMT); benign tumors with hyperplasia and intraductal papillary carcinoma show higher levels of IL-10 than the normal mammary glands30. This evidence concerns the gene IL10 and benign neoplasm.